DUBLIN, Nov. 01, 2022 (GLOBE NEWSWIRE) — The “Dried Bloodstain Trading Cards Market Size, Share and Trends Analysis Report by Application (Newborn Screening, Infectious Diseases, Forensics), By Card Type, By Region and Segment Forecasts, 2022-2030” Report has been added ResearchAndMarkets.com Offer.
The global market size of Dried Bloodstain Collection Cards is expected to reach USD 517.2 million by 2030, growing at a CAGR of 4.2% from 2022-2030. Dried Bloodstain (DBS) collection cards are used to diagnose infectious diseases, particularly in resource-constrained areas or to screen newborns for congenital metabolic problems, with a number of new and innovative DBS applications only recently emerging.
Increasing research studies on DBS tests and their benefits for diagnostic purposes are expected to spur market growth over the forecast period. In addition, the WHO recently recommended dried blood collection cards for the diagnosis of HIV and hepatitis B & C due to the advantages of DBS in blood collection and transport.
Additionally, dried bloodstain collection cards have been used in a variety of toxicology applications, including toxicokinetics, epidemiological, environmental, and forensic toxicology. Dried bloodstain collection cards are expected to be used as a sample preparation approach in forensic toxicology and can inexpensively preserve evidence for closed cases. Screening procedures and tracking markers of clinical or forensic interest are other toxicology applications where these maps can increasingly be used.
Developing countries in Africa and Asia have the highest prevalence of rabies. The detection and surveillance of such diseases is hampered by the lack of clinical laboratories. Dried bloodstain trading cards allow rabies to be diagnosed with limited resources. According to data released by the Australian Trade and Investment Commission, Australia is home to a thriving network of more…
